They have a handful of FDA approved drugs - portfolio includes four approved medicines -2 that are first- or best-in-class in their respective indications across solid tumours and hematologic malignancies, including three ADCs: ADCETRIS®(brentuximab vedotin), PADCEV®(enfortumab vedotin), and TIVDAK®(tisotumab vedotin).
Why IMU is a multi multi bagger, page-21870
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.002(4.35%) |
Mkt cap ! $357.0M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.9¢ | 4.6¢ | $977.7K | 20.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3232340 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 854027 | 4 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |